EdgarLookup

Cormorant Asset Management, LP

Insider transactions at 11 companies

This page shows all SEC Form 4 filings attributed to Cormorant Asset Management, LP. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

ERAS KNSA GLUE EYPT AVIR DRUG DSGN IMRX CRBP PYXS BMEA
Company Title Type Shares Price Value Date
EYPT Sale 60,000 $15.70 $942,000 Dec 4, 2025
DRUG Purchase 184,331 $21.70 $3,999,983 Nov 4, 2024
EYPT Purchase 642,847 $11.70 $7,521,310 May 6, 2024
CRBP Purchase 750,000 $19.00 $14,250,000 Feb 2, 2024
EYPT Purchase 750,000 $19.75 $14,812,500 Jan 9, 2024
EYPT Purchase 588,235 $17.00 $9,999,995 Dec 8, 2023
0001990550 Purchase 1,307,311 $6.99 $9,138,104 Oct 23, 2023
0001836056 Purchase 751,233 $9.24 $6,941,393 Sep 15, 2023
ERAS Purchase 307,692 $6.50 $1,999,998 Dec 13, 2022
ERAS Purchase 307,692 $6.50 $1,999,998 Dec 13, 2022
PYXS C 668,854 Oct 13, 2021
IMRX Purchase 550,000 $15.00 $8,250,000 Aug 3, 2021
ERAS Purchase 950,000 $16.00 $15,200,000 Jul 20, 2021
GLUE Purchase 600,000 $19.00 $11,400,000 Jun 28, 2021
BMEA Purchase 900,000 $17.00 $15,300,000 Apr 20, 2021
DSGN C 4,364,844 Mar 30, 2021
AVIR C 6,411,355 Nov 3, 2020
0001595893 Option Exercise 23,268 $2.19 $50,957 May 14, 2019
0001595893 Purchase 400,000 $18.00 $7,200,000 Apr 22, 2019
KNSA C 830,999 May 29, 2018